Lovenox) 40 mg daily or; Fondaparinux 2.5 mg daily or; Dalteparin 5000 IU daily; Course. Lesser saphenous vein thrombophlebitis: its natural history and implications for management. [Medline]. Less suitable for prescribing. J Thromb Haemost. Schönauer V, Kyrle PA, Weltermann A, Minar E, Bialonczyk C, Hirschl M, et al. Dermatol Online J. The affected vein might be near the surface of your skin (superficial thrombophlebitis) or deep within a muscle (deep vein thrombosis, or DVT). 10(5):833-9. . [Medline]. Am J Emerg Med. I feel spaced out, and yesterday I forgot all about my medical appointment. Cochrane Database Syst Rev. The clots usually resolve on their own, typically within several weeks. Am J Cancer. J Thromb Haemost. 4:CD004982. [Medline]. [Medline]. Primary hypercoagulable states, Superficial thrombophlebitis and risk for recurrent venous thromboembolism, Mondor's disease of the breast: sonographic and mammographic findings, A rapid D‐dimer assay in patients presenting at the emergency room with suspected acute venous thrombosis: accuracy and relation to clinical variables, British Committee for Standards in Haematology, Guidelines on the investigation and management of venous thrombosis at unusual sites, Therapeutic management of superficial venous thrombosis with calcium nadroparin. 32 (2):90-5. The other group of drugs for the treatment of superficial thrombophlebitis are anticoagulants. If the clot extends to where the superficial and deep, larger veins join, a DVT can develop. To diagnose thrombophlebitis, your doctor will ask you about your discomfort and look for affected veins near your skin's surface. The primary outcome measure was the incidence of … J Vasc Surg. The incidence of clinically significant nonmajor bleeding was 2.5% at 45 days and 2.5% at 90 days for rivaroxaban versus 0.4% at 45 days and 0.9% at 90 days for fondaparinux. Rivaroxaban 10 mg once daily was shown to be noninferior to fondaparinux 2.5 mg once daily for treatment of superficial venous thrombosis. • Isolated SVT ≥5 cm in length located >3 cm from the SFJ should receive prophylactic doses of fondaparinux (2.5 mg subcutaneously per day), rivaroxaban 10 mg po daily or prophylactic/intermediate doses of LMWH (see Table 1) for 45 days. Superficial thrombophlebitis: If the vein that has the clot is just under the skin, it is called a superficial venous thrombosis or superficial thrombophlebitis. Proximal superficial clot (upper thigh) especially within 5 cm of deep system or ; Clot >7 cm long in leg (or 5 cm long in arm) or; Known clotting disorder or; Lack of improvement after 1 week; Management. Vincent Lopez Rowe, MD Professor of Surgery, Program Director, Integrated Vascular Surgery Residency and Fellowship, Department of Surgery, Division of Vascular Surgery and Endovascular Therapy, Keck School of Medicine of the University of Southern California Blood coagulation (thrombin) and protein C pathways. Vasc Endovascular Surg. In 1846, the German pathologist Virchow showed that damage to a blood vessel wall, abnormal blood flow, or a change in blood constituents causing abnormal blood clotting, could lead to inflammation or formation of blood clots in the veins. 2012 Jul 15. Last medically reviewed on September 17, 2018 Superficial vein thrombosis (also known as superficial thrombophlebitis) results from thrombus formation in a superficial vein (most commonly the saphenous vein and its tributaries of the lower limbs), with associated inflammation in the tissue surrounding the vein. 2010 Sep 23. Nazir SS, Khan M. Thrombosis of the dorsal vein of the penis (Mondor's Disease): A case report and review of the literature. 1999 Dec. 30 (6):1113-5. [Medline]. Can ibuprofen cause memory problems? In 1846, the German pathologist Virchow showed that damage to a blood vessel wall, abnormal blood flow, or a change in blood constituents causing abnormal blood clotting, could lead to inflammation or formation of blood clots in the veins. Most bouts of superficial thrombophlebitis occur in a leg vein. 79 (4):741-2. . 2005 Jun. I've only been taking it for 3 days. [Medline]. 5 mg with rivaroxaban 10 mg/day for 45 days (ClinicalTrials.gov identifier NCT01499953). J Thromb Haemost. When the inflammation settles, you may be left with darkened skin and the lump may take 3 or 4 months to go. Dr. prescribed 600mgs. Gaffo AL. Consider a thrombophilia screen (check with haematology team). Pearson T, Bremmer M, Cohen J, Driscoll M. Vasculopathy related to cocaine adulterated with levamisole: A review of the literature. [Medline]. 363 (13):1222-32. DISCHARGE INSTRUCTIONS: Call your local emergency number (911 in the US) if: Traditionally, it has been considered a disease of the lower extremity. In addition, NSAIDs are often more practical and more easily administered than LMWH. Both treatment groups showed a significant reduction in … Superficial thrombophlebitis frequently occurs in leg veins that are dilated or leaky (varicose veins). Best Pract Res Clin Rheumatol. If you’re planning a long trip or you have risk factors for superficial thrombophlebitis, talk to your doctor about taking a low dose of aspirin daily. Cochrane Database Syst Rev. We studied the effectiveness and safety of treatment with dalteparin compared with ibuprofen in patients with confirmed superficial thrombophlebitis. Superficial thrombophlebitis, often just referred to as ‘phlebitis’, is inflammation of a vein just under the skin, usually in the leg. Superficial vein thrombosis (also known as superficial thrombophlebitis) results from thrombus formation in a superficial vein (most commonly the saphenous vein and its tributaries of the lower limbs), with associated inflammation in the tissue surrounding the vein. Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. Nagoya, Japan: University of Nagoya Press; 1990. McColl MD, Ramsay JE, Tait RC, Walker ID, McCall F, Conkie JA, et al. Rathbun SW, Aston CE, Whitsett TL. Superficial vein thrombosis: incidence in association with pregnancy and prevalence of thrombophilic defects. Superficial thrombophlebitis is an inflammation of the superficial veins associated with superficial vein thrombosis (SVT). Superficial thrombophlebitis in lower-extremity varicose veins has an extremely low incidence of DVT 10).After an initial diagnosis of superficial thrombophlebitis, especially in the thigh region, a follow-up duplex ultrasonographic examination in 48 to 72 hours should be performed to look for progression of disease after treatment is initiated. CD004982. 26 (3):431-3. 2012 Aug 21. 52:1319. [Medline]. Superficial thrombophlebitis diagnosed by duplex scanning. 2007 Apr 18. [Full Text]. Adam J Rosh, MD Assistant Professor, Program Director, Emergency Medicine Residency, Department of Emergency Medicine, Detroit Receiving Hospital, Wayne State University School of Medicine Bijsterveld NR, Moons AH, Boekholdt SM, van Aken BE, Fennema H, Peters RJ, et al. Srp Arh Celok Lek. Wichers IM, Di Nisio M, Büller HR, Middeldorp S. Treatment of superficial vein thrombosis to prevent deep vein thrombosis and pulmonary embolism: a systematic review. Carcinoma and venous thrombosis: Frequency of association of carcinoma in body or tail of pancreas with multiple venous thrombosis. Hi, I was just diagnosed with superficial thrombophlebitis. Protein S deficiency in repetitive superficial thrombophlebitis. If you’re planning a long trip or you have risk factors for superficial thrombophlebitis, talk to your doctor about taking a low dose of aspirin daily. [Medline]. Thrombophlebitis is a very real risk with the foam sclerotherapy procedure; that is why we opt for the microstab phlebectomy procedure in treating varicosities. The efficacy of nonsteroidal anti-inflammatory drugs (NSAIDs) is similar to that of LMWH in reducing the risk of extension of superficial thrombophlebitis into the … : There is no best medication for superficial phlebitis. Quéré I, Leizorovicz A, Galanaud JP, Presles E, Barrellier MT, Becker F, et al. DISCHARGE INSTRUCTIONS: Call your local emergency number (911 in the US) if: The cause of superficial thrombophlebitis is not completely clear but it is believed to be associated with a change in the dynamic balance of haemostasis. The inflammation causes a blood clot to form in your vein. Medical treatment: Nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen can be useful to ease the pain and reduce the risk of extension. Wafarin maintenance dosing nomogram; LMWH dosing guidelines ; Neuraxial guidelines; Antithrombotic reversal guidelines; Warfarin teaching … 3 (6):1152-7. 86 (1):112-23. Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B, et al. Lozano FS, Almazan A. Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis: a prospective study. 157 (4):JC2-4. 2012 May. An unexpectedly high rate of pulmonary embolism in patients with superficial thrombophlebitis of the thigh. Lutter KS, Kerr TM, Roedersheimer LR, et al. However, in a small number of cases, complications can occur with superficial thrombophlebitis, including extension of the blood clot further up the vein. Ann Intern Med. It is due to inflammation, which may be accompanied by thrombosis, and less … Hi, I was just diagnosed with superficial thrombophlebitis. 2003 Apr. Superficial thrombophlebitis signs and symptoms include: Warmth, tenderness and pain in the affected area; Redness and swelling; Deep vein thrombosis signs and symptoms include: Pain; Swelling; When a vein close to the surface of your skin is affected, you might see a red, hard cord just under the surface of your skin that's tender to the touch. Note lack of full compressibility of vein secondary to intraluminal thrombus. Bachmeyer C, Elalamy I. Rivaroxaban as an effective treatment for recurrent superficial thrombophlebitis related … A randomized trial of dalteparin compared with ibuprofen for the treatment of superficial thrombophlebitis. Dosage testing and comparison with a non‐steroidal anti‐inflammatory agent], Phlegmasia alba dolens Edited by Clinique Medicale de L'Hotel‐Dieu Paris, A comparison of low‐molecular‐weight heparin and combined therapy of low‐molecular‐weight heparin with an anti‐inflammatory agent in the treatment of superficial vein thrombosis, Superficial thrombophlebitis of the lower limbs in patients with varicose veins, An unexpectedly high rate of pulmonary embolism in patients with superficial thrombophlebitis of the thigh, Spontaneous superficial venous thrombophlebitis: does it increase risk for thromboembolism? This type of clot does not usually travel to the lungs unless it reaches the deep veins. David FM Brown, MD Associate Professor, Division of Emergency Medicine, Harvard Medical School; Vice Chair, Department of Emergency Medicine, Massachusetts General Hospital, David FM Brown, MD is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine, Ryan Doss, MD Resident Physician, Department of Emergency Medicine, Detroit Medical Center, Wayne State University School of Medicine, Ryan Doss, MD is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, Emergency Medicine Residents Association, Michigan College of Emergency Physicians, and Michigan State Medical Society, Craig F Feied, MD, FACEP, FAAEM, FACPh, Professor of Emergency Medicine, Georgetown University School of Medicine; General Manager, Microsoft Enterprise Health Solutions Group, Craig F Feied, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Phlebology, American College of Physicians, American Medical Association, American Medical Informatics Association, American Venous Forum, Medical Society of the District of Columbia, Society for Academic Emergency Medicine, and Undersea and Hyperbaric Medical Society, Jonathan A Handler, MD, HSG Chief Deployment Architect, Microsoft Corporation, Adjunct Associate Professor, Department of Emergency Medicine, Northwestern University, Feinberg School of Medine, Jonathan A Handler, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine, Jeffrey Lawrence Kaufman, MD Associate Professor, Department of Surgery, Division of Vascular Surgery, Tufts University School of Medicine, Jeffrey Lawrence Kaufman, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Surgeons, American Society for Artificial Internal Organs, Association for Academic Surgery, Association for Surgical Education, Massachusetts Medical Society, Phi Beta Kappa, and Society for Vascular Surgery, Samuel M Keim, MD Associate Professor, Department of Emergency Medicine, University of Arizona College of Medicine, Samuel M Keim, MD is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American Medical Association, American Public Health Association, and Society for Academic Emergency Medicine, Robert G Klever Jr, MD Resident Physician, Department of Emergency Medicine, Detroit Receiving Hospital, Wayne State University School of Medicine, Robert G Klever Jr, MD is a member of the following medical societies: American College of Emergency Physicians, Emergency Medicine Residents Association, and Society for Academic Emergency Medicine, Eddy S Lang, MDCM, CCFP(EM), CSPQ Associate Professor, Senior Researcher, Division of Emergency Medicine, Department of Family Medicine, University of Calgary Faculty of Medicine; Assistant Professor, Department of Family Medicine, McGill University Faculty of Medicine, Canada, Eddy S Lang, MDCM, CCFP(EM), CSPQ is a member of the following medical societies: American College of Emergency Physicians, Canadian Association of Emergency Physicians, and Society for Academic Emergency Medicine, William A Marston, MD, Associate Professor, Department of Surgery, Division of Vascular Surgery, University of North Carolina School of Medicine, William A. Marston, MD is a member of the following medical societies: American College of Surgeons, American Venous Forum, North Carolina Medical Society, Peripheral Vascular Surgery Society, and Southern Association for Vascular Surgery, Nelson S Menezes, MD, FRCS(Edin), FACS Assistant Professor of Surgery, Weill Cornell Medical College; Chief of Vascular Surgery, Department of Surgery, Brooklyn Hospital Center, Nelson S Menezes, MD, FRCS(Edin), FACS is a member of the following medical societies: American College of Surgeons, International Society of Endovascular Specialists, Medical Society of the State of New York, and Society for Vascular Surgery, Travis J Phifer, MD Chief, Division of Vascular Surgery, Professor, Department of Surgery and Radiology, Louisiana State University Health Sciences Center in Shreveport, Travis J Phifer, MD is a member of the following medical societies: American College of Emergency Physicians, American College of Surgeons, American Medical Association, Association for Academic Surgery, Society for Academic Emergency Medicine, Society for Vascular Surgery, and Society of Critical Care Medicine, Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference. A randomized trial of dalteparin compared with ibuprofen for the treatment of superficial thrombophlebitis. Attachment: Management of Superficial Vein Thrombosis.pdf. Thromb Haemost. Vasc Endovascular Surg. Elevating the affected limb, using a warm washcloth to apply … [Medline]. Prandoni P, Tormene D, Pesavento R, Vesalio Investigators Group. 2013 Feb. 27 (1):57-67. Compression stockings were not routinely prescribed. Thrombosis in vasculitis. If symptoms of superficial thrombophlebitis were not resolved at day 7–9, in the absence of thrombus extension, the patient received an additional 7 days of the blinded therapy. [Medline]. 184:57. Superficial thrombophlebitis is the term for an inflamed vein near the surface of the skin (usually a ... take anti-inflammatory painkillers, such as ibuprofen; rub an anti-inflammatory cream or gel on the area if the affected area is only small; What's the outlook? Ultrasound. I am worried about taking such high doses. 292 (6521):658-9. BACKGROUND: Superficial thrombophlebitis can produce pain and result in a deep vein thrombosis (DVT) if not treated. Superficial thrombophlebitis (STP) is inflammation of a vein just under your skin (superficial vein). DVT‐deep vein thrombosis, SFJ‐sapheno‐femoral junction, SVT‐superficial vein thrombosis, LMWH‐low molecular weight heparin, PE‐pulmonary embolus, VTE‐venous thrombosis, UFH‐unfractionated heparin, CUS‐compression ultrasonography, h‐hour. 4 (3):e105-e113. 110 (1):42-6. If the symptoms had not resolved by day 7–9, in the absence of thrombus extension, a further 7 days of treatment was administered. 106 (20):2550-4. [Medline]. The inflammation causes a blood clot to form in your vein. 2016 May. Stevens SM. Gillet JL, Ffrench P, Hanss M, Allaert FA, Chleir F. [Predictive value of D-dimer assay in superficial thrombophlebitis of the lower limbs]. 1998 Sep. 16 (5):508-11. The full text of this article hosted at iucr.org is unavailable due to technical difficulties. Superficial thrombophlebitis frequently occurs in leg veins that are dilated or leaky (varicose veins). J Vasc Surg. Although any superficial vein can be involved, SVT is most often observed in the lower extremities with greater saphenous vein (GSV) involvement in 60-80% of affected individuals. Thrombophlebitis means there is a blood clot in the vein (thrombosis or thromboembolism) that causes swelling and pain. A pilot randomized double-blind comparison of a low-molecular-weight heparin, [Medline]. J Thromb Haemost. None of the authors have any competing financial or conflict of interest associated with the topic of this review. 2007 Apr. For people who find it difficult to swallow tablets or capsules, ibuprofen is available as a tablet that melts in your mouth, granules that you mix with a glass of water to make a drink, and as a syrup. Superficial thrombophlebitis is the term for an inflamed vein near the surface of the skin (usually a ... take anti-inflammatory painkillers, such as ibuprofen; rub an anti-inflammatory cream or gel on the area if the affected area is only small; What's the outlook? Arch Intern Med 1997; 157:1822. . Please check your email for instructions on resetting your password. JAMA. [Medline]. We studied the effectiveness and safety of treatment with dalteparin compared with ibuprofen in patients with confirmed superficial thrombophlebitis. Courtesy of Wikimedia Commons ©Nevit Dilmen. Di Nisio M, Wichers IM, Middeldorp S. Treatment for superficial thrombophlebitis of the leg. 1998 Apr. The new guidelines can be found in the VTE section of this website. 1969 Oct. 170 (4):547-58. In the most recent study to compare LMWH with NSAIDs, patients were randomized to dalteparin (200 units/kg first dose, then 10 000 units/day for 6 additional days) versus ibuprofen 800 mg three times daily for 7 days. Should not be used on large areas of skin, broken or sensitive skin, or mucous membranes. But until they do, the condition can be quite uncomfortable. Medicinal forms. Answer. STP most often happens in your leg but may also happen in your arm. Leave a gap of 10 to 12 hours between doses if you're taking ibuprofen twice a day. But, superficial thrombophlebitis can be painful and treatment may be needed. 1932. Mar 2019 [internet publication]. 1986 Mar 8. Rosendaal FR, Helmerhorst FM, Vandenbroucke JP. Di Minno MN, Ambrosino P, Ambrosini F, Tremoli E, Di Minno G, Dentali F. Prevalence of deep vein thrombosis and pulmonary embolism in patients with superficial vein thrombosis: a systematic review and meta-analysis. Can ibuprofen cause memory problems? A controversial association, Progression of superficial venous thrombosis to deep vein thrombosis, A randomized double‐blind study of low‐molecular‐weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum), Treatment of superficial vein thrombosis with standardized application of Essaven gel ‐a placebo‐controlled, randomized study, A pilot randomized double‐blind comparison of a low‐molecular‐weight heparin, a nonsteroidal anti‐inflammatory agent, and placebo in the treatment of superficial vein thrombosis, POST (Prospective Observational Superficial Thrombophlebitis) Study Group, Superficial venous thrombosis and venous thromboembolism: a large, prospective epidemiologic study, Fondaparinux for the treatment of superficial‐vein thrombosis in the legs, Treatment for superficial thrombophlebitis of the leg, Annual diagnosis rate of superficial‐vein thrombosis of the lower limbs: the STEPH community‐based study, Predictive value of D‐dimer assay in superficial thrombophlebitis of the lower limbs, Handbook of venous disorders: Guidelines of the American Venous Forum, The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum, Thrombophlebitis of the great saphenous vein–recommendations for treatment, NICE guideline: management of venous thromboembolic diseases and role of thrombophilia testing, Treatment of superficial vein thrombosis: clinical evaluation of Essaven gel‐a placebo‐controlled, 8‐week, randomized study, The incidence of deep venous thrombosis in patients with superficial thrombophlebitis of the lower limbs, Superficial vein thrombosis: a consensus statement, Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence‐based clinical practice guidelines, Increased risk of venous thrombosis in persons with clinically diagnosed superficial vein thrombosis: results from the MEGA study, Clinical relevance of symptomatic superficial‐vein thrombosis extension: lessons from the CALISTO study, Low‐molecular‐weight heparin versus saphenofemoral disconnection for the treatment of above‐knee greater saphenous thrombophlebitis: a prospective study, Superficial thrombophlebitis diagnosed by duplex scanning, Genetic risk factors for superficial vein thrombosis, Superficial vein thrombosis of lower limbs: influence of factor V Leiden, factor II G20210A and overweight, Clinical Knowledge Summary Thrombophlebitis ‐ superficial, High vs. low doses of low molecular‐weight heparin for the treatment of superficial vein thrombosis of the legs: a double‐blind, randomized trial, Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosis, Prospective Observational Superficial Thrombophlebitis (POST) Study Investigators, Superficial venous thrombosis and compression ultrasound imaging, A randomized trial of dalteparin compared with ibuprofen for the treatment of superficial thrombophlebitis, Superficial thrombophlebitis. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, et al. All material on this website is protected by copyright, Copyright © 1994-2021 by WebMD LLC. Migratory or recurrent thrombophlebitis is an indication for a more detailed search for a malignant lesion, or Behcet's syndrome or Buerger's disease. Superficial thrombophlebitis and risk for recurrent venous thromboembolism. Skin necrosis and venous thrombosis from subcutaneous injection of charcoal lighter fluid (naptha). [Medline]. Hirudoid ® is less suitable for prescribing. Blood may pool and clot in these abnormal veins, leading to pain, redness, swelling and tenderness in the affected area. Taking ibuprofen with other painkillers. Prevention of thromboembolic complications in patients with superficial-vein thrombosis given rivaroxaban or fondaparinux: the open-label, randomised, non-inferiority SURPRISE phase 3b trial. If the clot extends to where the superficial and deep, larger veins join, a DVT can develop. ibuprofen 4 times daily. For Adult. The cause of superficial thrombophlebitis is not completely clear but it is believed to be associated with a change in the dynamic balance of haemostasis. Superficial Thrombophlebitis Upper Extremity Superficial Thrombophlebitis Lower Extremity Superficial Thrombophlebitis: Intervention : Drug: Dalteparin sodium injection: Enrollment 72 Participant Flow . 2012; 10(5):833-9 (ISSN: 1538-7836) Rathbun SW; Aston CE; Whitsett TL. Superficial thrombophlebitis (STP) is inflammation of a vein just under your skin (superficial vein). 2013 Apr 30. Patients can also receive Your best course of action at this point is to continue to wear compression, which I assume you are doing. [Medline]. Any antiinflammatory that is tolerated by the patient is acceptable. [Medline]. GS, AJM and RA co‐authored this manuscript. But, superficial thrombophlebitis … Rivaroxaban 10 mg once daily was shown to be noninferior to fondaparinux 2.5 mg once daily for treatment of superficial venous thrombosis. DeTakats G. "Resting Infection" in varicose veins, its diagnosis and treatment. 2009 Jul 1. However, any superficial vein What is thrombophlebitis? [Medline]. Bergqvist D, Jaroszewski H. Deep vein thrombosis in patients with superficial thrombophlebitis of the leg. To the skin. Drugs like fondaparinux and low-molecular-weight heparin act like blood thinners, reducing clot formation. Clin Infect Dis. NSAIDs (e.g. 2012 May. N Engl J Med. Khanjan H Nagarsheth, MD, MBA is a member of the following medical societies: Academic Surgical Congress, American College of Surgeons, American Venous Forum, Association of Trauma and Military Surgery, Eastern Association for the Surgery of Trauma, Eastern Vascular Society, Knoxville Academy of Medicine, Society for Clinical Vascular Surgery, Society for Vascular Surgery, Society of American Gastrointestinal and Endoscopic Surgeons, Society of Critical Care Medicine, Southeastern Surgical Congress, Tennessee Medical Association, Vascular Society of New JerseyDisclosure: Nothing to disclose. Superficial Thrombophlebitis, Superficial Vein Thrombosis. [Medline]. Superficial thrombophlebitis: If the vein that has the clot is just under the skin, it is called a superficial venous thrombosis or superficial thrombophlebitis. Wet heat to the area also helps and an evaluation by a vein specialist would also be recommended. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly93d3cubWVkc2NhcGUuY29tL2Fuc3dlcnMvNDYzMjU2LTE2MDA0NC9hcmUtbnNhaWRzLWVmZmVjdGl2ZS1mb3ItdGhlLXRyZWF0bWVudC1vZi1zdXBlcmZpY2lhbC10aHJvbWJvcGhsZWJpdGlz.